Indian River County is making significant structural changes to its employee healthcare benefits for the upcoming fiscal year. Facing ballooning medical costs and severe budget overruns, the county commission recently voted to eliminate insurance coverage for popular GLP-1 weight-loss medications, a decision that will impact over 4,000 local government employees and their dependents.
By cutting coverage for expensive weight-loss medications and increasing plan premiums by 25 percent, Indian River County aims to curb an $8.1 million deficit while keeping its broader employee healthcare system sustainable for the future.
The rapid rise in the popularity of medications such as Ozempic and Wegovy has placed substantial financial strain on the county’s health insurance program. Originally developed to treat type 2 diabetes and later approved by the FDA for weight loss, these weekly injectable drugs cost insurance providers between $1,000 and $1,400 per month. Over the past three years, the number of county employees utilizing these prescriptions surged from just 37 in 2023 to a peak of nearly 300. Currently, 260 local government employees are actively taking glucagon-like peptide-1 medications. Eliminating this specific coverage is projected to save Indian River County approximately $3.3 million next year.
In addition to the removal of GLP-1 coverage, the county is implementing across-the-board increases to healthcare premiums, deductibles, and copays. The county’s health insurance costs went $2 million over budget last year and are currently projected to be $8.1 million over budget this year. Without immediate intervention, total employee healthcare spending was on track to reach $36.9 million next year, exceeding long-term budget projections by $11.4 million. To help bridge this financial gap, employee premiums will be capped at a 25 percent increase for all program members, a move that will generate an additional $2
